Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins.
Grifantini R, Pagani M, Pierleoni A, Grandi A, Parri M, Campagnoli S, Pileri P, Cattaneo D, Canidio E, Pontillo A, De Camilli E, Bresciani A, Marinoni F, Pedrazzoli E, Nogarotto R, Abrignani S, Viale G, Sarmientos P, Grandi G. Grifantini R, et al. Among authors: parri m. J Proteomics. 2011 Dec 21;75(2):532-47. doi: 10.1016/j.jprot.2011.08.018. Epub 2011 Sep 5. J Proteomics. 2011. PMID: 21920474
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer.
Parri M, Pietrovito L, Grandi A, Campagnoli S, De Camilli E, Bianchini F, Marchiò S, Bussolino F, Jin B, Sarmientos P, Grandi G, Viale G, Pileri P, Chiarugi P, Grifantini R. Parri M, et al. Angiogenesis. 2014 Oct;17(4):881-96. doi: 10.1007/s10456-014-9435-4. Epub 2014 Jun 6. Angiogenesis. 2014. PMID: 24903490
FAT1: a potential target for monoclonal antibody therapy in colon cancer.
Pileri P, Campagnoli S, Grandi A, Parri M, De Camilli E, Song C, Ganfini L, Lacombe A, Naldi I, Sarmientos P, Cinti C, Jin B, Grandi G, Viale G, Terracciano L, Grifantini R. Pileri P, et al. Among authors: parri m. Br J Cancer. 2016 Jun 28;115(1):40-51. doi: 10.1038/bjc.2016.145. Epub 2016 Jun 21. Br J Cancer. 2016. PMID: 27328312 Free PMC article.
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer.
Grandi A, Santi A, Campagnoli S, Parri M, De Camilli E, Song C, Jin B, Lacombe A, Castori-Eppenberger S, Sarmientos P, Grandi G, Viale G, Terracciano L, Chiarugi P, Pileri P, Grifantini R. Grandi A, et al. Among authors: parri m. Oncotarget. 2016 Sep 27;7(39):63596-63610. doi: 10.18632/oncotarget.11550. Oncotarget. 2016. PMID: 27566589 Free PMC article.
Some Gram-negative Lipoproteins Keep Their Surface Topology When Transplanted from One Species to Another and Deliver Foreign Polypeptides to the Bacterial Surface.
Fantappiè L, Irene C, De Santis M, Armini A, Gagliardi A, Tomasi M, Parri M, Cafardi V, Bonomi S, Ganfini L, Zerbini F, Zanella I, Carnemolla C, Bini L, Grandi A, Grandi G. Fantappiè L, et al. Among authors: parri m. Mol Cell Proteomics. 2017 Jul;16(7):1348-1364. doi: 10.1074/mcp.M116.065094. Epub 2017 May 8. Mol Cell Proteomics. 2017. PMID: 28483926 Free PMC article.
Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles.
Grandi A, Tomasi M, Zanella I, Ganfini L, Caproni E, Fantappiè L, Irene C, Frattini L, Isaac SJ, König E, Zerbini F, Tavarini S, Sammicheli C, Giusti F, Ferlenghi I, Parri M, Grandi G. Grandi A, et al. Among authors: parri m. Front Oncol. 2017 Nov 7;7:253. doi: 10.3389/fonc.2017.00253. eCollection 2017. Front Oncol. 2017. PMID: 29164053 Free PMC article.
TCTN2: a novel tumor marker with oncogenic properties.
Cano-Rodriguez D, Campagnoli S, Grandi A, Parri M, Camilli E, Song C, Jin B, Lacombe A, Pierleoni A, Bombaci M, Cordiglieri C, Ruiters MH, Viale G, Terracciano L, Sarmientos P, Abrignani S, Grandi G, Pileri P, Rots MG, Grifantini R. Cano-Rodriguez D, et al. Among authors: parri m. Oncotarget. 2017 Aug 24;8(56):95256-95269. doi: 10.18632/oncotarget.20438. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221125 Free PMC article.
Vaccination With a FAT1-Derived B Cell Epitope Combined With Tumor-Specific B and T Cell Epitopes Elicits Additive Protection in Cancer Mouse Models.
Grandi A, Fantappiè L, Irene C, Valensin S, Tomasi M, Stupia S, Corbellari R, Caproni E, Zanella I, Isaac SJ, Ganfini L, Frattini L, König E, Gagliardi A, Tavarini S, Sammicheli C, Parri M, Grandi G. Grandi A, et al. Among authors: parri m. Front Oncol. 2018 Oct 26;8:481. doi: 10.3389/fonc.2018.00481. eCollection 2018. Front Oncol. 2018. PMID: 30416985 Free PMC article.
72 results